The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period. The growth of this market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.
The endotherapy devices segment accounted for the largest share of the endoscopic retrograde cholangiopancreatography market in 2020. Based on products, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.
The markets in Asia Pacific and Latin America is projected to witness the highest growth rate during the forecast period (2021–2026). North America accounted for the largest share of the Endoscopic retrograde cholangiopancreatography market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
A breakdown of the primary participants referred to for this report is provided below: • By Company Type (Supply-side): Tier 1: 55%, Tier 2: 25%, and Tier 3: 20% • By Designation: C-level: 43%, Director-level: 32%, and Others: 25% • By Region: North America: 38%, Europe: 23%, Asia-Pacific: 29%, Latin America: 5%, and Middle East & Africa: 5% The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co.KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B.
Braun Melsungen AG (Germany). Other players in the market include Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instrument Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (US), and Shaili Endoscopy (India).
Research Coverage: The report analyzes the endoscopic retrograde cholangiopancreatography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.
This report provides insights into the following pointers: • Market Penetration: Comprehensive information on the product portfolios of the top players in the endoscopic retrograde cholangiopancreatography market. The report analyzes the market based on the products and region. • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the endoscopic retrograde cholangiopancreatography market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of endoscopic retrograde cholangiopancreatography solutions across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the endoscopic retrograde cholangiopancreatography market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the endoscopic retrograde cholangiopancreatography markets.
Our reports have been used by over 10K customers, including:
The global medical laser systems market was valued at US$2.95 billion in 2021, and is projected to be worth US$5.79 billion in 2026. Laser therapy is a medical procedure that involves cutting, burning, or dissolving tissue with a strong laser beam. A medical laser is a non-invasive, high-intensity light source that can be used to treat tissue...
The US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period. The growth of this market is mainly attributed to the growing prevalence of cancer, rise in chronic diseases, increased investment in health facilities, technological...
The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery....
This study considers a detailed scenario of the present medical ventilators market and its market dynamics for 2022?2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent...
The soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically...
The US healthcare/hospital food services market is projected to reach USD 22.8 billion by 2026 from USD 13.2 billion in 2021, at a CAGR of 11.5% during the forecast period. The growth of this market is mainly attributed to the increasing prevalence of and awareness about chronic diseases, growing focus on improved patient food experience,...
Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient.Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions...
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The patient engagement technology market is expected to grow from US$ 21,354.38 million in 2022 to US$ 59,003.21 million by 2028; it is estimated to grow at a CAGR of 18.5% from 2022 to 2028. Increasing prevalence of chronic disorders such as cardiovascular disorders, diabetes, and obesity, the surge in government initiatives, and the...
The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing...
Healthcare
Sporting Goods
World
United Kingdom
Europe
APAC
Overweight Prevalence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.